What Vaccine Congress Washington Speakers Say

 

Jennifer Nuzzo

Jennifer Nuzzo
Brown University School of Public Health

 

David C Kaslow

David C. Kaslow
PATH

 

James E Crowe

James E. Crowe
Vanderbilt Vaccine Center

 

WASHINGTON, D.C. (April 18, 2022)—After making significant progress in vaccinating Americans against COVID-19 and slowing its spread, infectious disease researchers are now alarmed that the nation will not be able to prevent another pandemic unless public health officials promptly take concrete steps to prepare.


Read full news release >

WASHINGTON, D.C. (April 19, 2022)—The unprecedented success of vaccine development during COVID-19 will not effectively fight against the inevitable next pandemic unless the world’s leaders can develop a better system for vaccinating billions of people, according to a leading researcher who addressed the 2022 World Vaccine Congress, a gathering of hundreds of global infectious disease experts.


Read full news release >  

WASHINGTON, D.C. (April 20, 2022)—New discoveries in the fight against influenza, including the targeted use of human monoclonal antibodies, may eventually lead toward the development of an elusive “universal” flu vaccine or antibody combination to combat an illness that kills up to 650,000 people worldwide, according to research to be presented at the 2022 World Vaccine Congress.


Read full news release >